Company · Oxford
Mitorx Therapeutics Limited
Research and experimental development on biotechnology
Official record Companies House · updated 27th September 2026 · Sources
Network
The large node is Mitorx Therapeutics Limited. Red nodes are organisations, white nodes are people. Sign in free to explore further.
Who leads it
Previous officers 3
- Dr David Mark Anthony Holbrook 2024-2025 View profile
- Matthew Loren Whiteman 2021-2025 View profile
- Dr Norman Milne Law 2021-2025 View profile
Directors and secretaries as filed at Companies House.
Do you help lead this organisation? Set up its network · How it works
About
- What it does
- Research and experimental development on biotechnology; Other business support service activities n.e.c.
- Incorporated
- 02/03/2021
- Registered office
- Oxford
- Previous names
- Iffley Biotech LTD (until 22/07/2021)
Ownership
Owned by (1) iOwned byIndividuals and companies registered as having significant control over this company, from the Companies House PSC (persons with significant control) register. People whose ownership could not be confirmed to one individual are not listed as confirmed owners.
- Jonathan David Rees ceased 2022-01-25
50-75% shares, 50-75% voting, appoints directors · notified 2021-03-02 - confirmed: also a director of this company
Group
- Mitorx Therapeutics Limited
is controlled by Jonathan David Rees
Evidence
ceased 50-75% shares, 50-75% voting, appoints directors · notified 2021-03-02, ceased 2022-01-25 · source: Companies House PSC register
Ultimately controlled by Jonathan David Rees.
Ownership paths are calculated from Companies House persons-with-significant-control filings. Each step shows the filed nature of control and dates; a step marked "ceased" is historical, not current.
Financials
- Net assets
- £1,396,954
- Total assets
- £1,396,954
- Cash
- £1,123,795
- Employees
- 9
- Turnover
- Not reported (small or micro-entity accounts)
Figures from accounts filed at Companies House (iXBRL), period ending 2025-03-31. Where turnover is absent, small and micro-entity accounts are not required to report it, so it is not shown as zero.
Board analysis
Board DNA
How this board is put together, from the Companies House officer record and Charity Commission trustee records - deterministic, no AI.iBoard compositionCounted from the dated Companies House officer record: the current directors only, past directors excluded.
5 directors on the board
- Alexander Michael Fink Director · appointed 2022
- Didier Shaun Philip Cowling Director · appointed 2025
- Mohammad Sohail Fazeli Director · appointed 2026
- Glyn Owain Edwards Director · appointed 2022
- Jonathan David Rees Director · appointed 2021
First-time vs portfolio directors
Portfolio (5)
- Alexander Michael Fink Director · appointed 2022
- Didier Shaun Philip Cowling Director · appointed 2025
- Mohammad Sohail Fazeli Director · appointed 2026
- Glyn Owain Edwards Director · appointed 2022
- Jonathan David Rees Director · appointed 2021
Also govern a charity
Left in the last 12 months
- Dr David Mark Anthony Holbrook Director · appointed 2024 · resigned 2025
- Dr Norman Milne Law Director · appointed 2021 · resigned 2025
- Matthew Loren Whiteman Director · appointed 2021 · resigned 2025
Where else this board sits iWhere else this board sitsThe charitable fields these directors govern in elsewhere, by Charity Commission classification. Excludes this company and any charity it is the legal face of.
The sectors these directors govern in elsewhere. This company, and any charity it is the legal face of, are excluded - counting them would just tell you what you are already looking at.
Sources
Official record from Companies House. Governance Register calculates the connections.
Record details
- Company number
- 13237941
- Status
- Active
- Type
- Private Limited Company
- Accounts next due
- 31/12/2026
- Edition
- Register edition compiled 27th September 2026
- Labels
- Official record from Companies House · Calculated derived by Governance Register.
Contains public sector information licensed under the Open Government Licence v3.0. Report an issue · How we handle data